Epoch Biodesign
London
About Epoch Biodesign
Epoch Biodesign develops natural solutions to scale and industrialize biology to solve climate challenges. Epoch Biodesign develops enzymes to enable previously unthinkable applications by combining unique insights from nature with deep expertise in computational and biological sciences. The company's solution is biorecycling, which is a tuneable enzymatic process that converts plastic waste into everyday chemicals.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $47.3M
- Last round: Series Unknown (Mar 2026)
- Website: epochbiodesign.com
- Phone: [email protected]
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/epoch-biodesign-45058 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.